These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study. Yu S; Sun Z; Zong L; Yan J; Yu M; Chen J; Lu Z J Gynecol Oncol; 2022 May; 33(3):e38. PubMed ID: 35320887 [TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification. Kim SR; Cloutier BT; Leung S; Cochrane D; Britton H; Pina A; Storness-Bliss C; Farnell D; Huang L; Shum K; Lum A; Senz J; Lee CH; Gilks CB; Hoang L; McAlpine JN Gynecol Oncol; 2020 Jul; 158(1):3-11. PubMed ID: 32331700 [TBL] [Abstract][Full Text] [Related]
9. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification. Thompson EF; Huvila J; Jamieson A; Leung S; Lum A; Offman S; Lytwyn A; Sur ML; Hoang L; Irving J; van der Westhuizen N; Morin C; Bicamumpaka C; Azordegan N; Gougeon F; Ennour-Idrissi K; Senz J; McConechy MK; Aguirre-Hernandez R; Lui V; Kuo C; Bell C; Salisbury T; Lawson J; He E; Wang S; Chiu D; Kean S; Samouëlian V; Salvador S; Gotlieb W; Helpman L; Scott S; Wohlmuth C; Vicus D; Plante M; Talhouk A; Huntsman D; Parra-Herran C; Kinloch M; Grondin K; Gilks CB; McAlpine JN; Mod Pathol; 2022 Dec; 35(12):1974-1982. PubMed ID: 36241860 [TBL] [Abstract][Full Text] [Related]
10. p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification. Jamieson A; Thompson EF; Huvila J; Gilks CB; McAlpine JN Int J Gynecol Cancer; 2021 Jun; 31(6):907-913. PubMed ID: 33589443 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the immune checkpoint lymphocyte activation gene-3 (LAG-3) in endometrial cancer: An emerging target for immunotherapy. Zhang Y; Yang R; Xu C; Zhang Y; Deng M; Wu D; Tang F; Liu X; Han Y; Zhan Y; Miao J Pathol Res Pract; 2022 Aug; 236():153990. PubMed ID: 35749914 [TBL] [Abstract][Full Text] [Related]
12. Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma. Britton H; Huang L; Lum A; Leung S; Shum K; Kale M; Burleigh A; Senz J; Yang W; McConechy M; Kommoss S; Brucker S; Talhouk A; Gilks CB; McAlpine JN Gynecol Oncol; 2019 Jun; 153(3):487-495. PubMed ID: 30922603 [TBL] [Abstract][Full Text] [Related]
13. Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population. Kang N; Zhang X; Wang Z; Dai Y; Lu S; Su W; Gai F; Zhu C; Shen D; Wang J Pathol Res Pract; 2024 Feb; 254():155152. PubMed ID: 38277742 [TBL] [Abstract][Full Text] [Related]
14. Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis. Travaglino A; Raffone A; Santoro A; Raimondo D; Angelico G; Valente M; Arciuolo D; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Seracchioli R; Zannoni GF Gynecol Oncol; 2021 Sep; 162(3):804-808. PubMed ID: 34266691 [TBL] [Abstract][Full Text] [Related]
15. The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients. Wu Q; Zhang N; Xie X BMC Cancer; 2022 Nov; 22(1):1157. PubMed ID: 36357827 [TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment. Leon-Castillo A; Horeweg N; Peters EEM; Rutten T; Ter Haar N; Smit VTHBM; Kroon CD; Boennelycke M; Hogdall E; Hogdall C; Nout RRA; Creutzberg CL; Ortoft G; Bosse T Gynecol Oncol; 2022 Mar; 164(3):577-586. PubMed ID: 35078648 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the TCGA molecular classification in uterine carcinosarcoma. Travaglino A; Raffone A; Raimondo D; Arciuolo D; Angelico G; Valente M; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Santoro A; Seracchioli R; Franco Zannoni G Int J Gynaecol Obstet; 2022 Jul; 158(1):13-20. PubMed ID: 34536971 [TBL] [Abstract][Full Text] [Related]
18. Risk stratification and molecular heterogeneity of endometrial cancer and expression profile of TIM-3: A retrospective cohort study. Zhang Y; Yang R; Xu C; Zhang Y; Deng M; Wu D; Tang F; Liu X; Han Y; Zhan Y; Miao J Gynecol Oncol; 2023 Mar; 170():210-220. PubMed ID: 36709662 [TBL] [Abstract][Full Text] [Related]
19. TCGA molecular classification in endometriosis-associated ovarian carcinomas: Novel data on clear cell carcinoma. Similä-Maarala J; Soovares P; Pasanen A; Ahvenainen T; Vahteristo P; Bützow R; Lassus H Gynecol Oncol; 2022 Jun; 165(3):577-584. PubMed ID: 35370008 [TBL] [Abstract][Full Text] [Related]
20. Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics. Huvila J; Jamieson A; Pors J; Hoang L; Mirkovic J; Cochrane D; McAlpine JN; Gilks CB Int J Gynecol Pathol; 2024 Sep; 43(5):506-514. PubMed ID: 38303106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]